F. Berti et al., INFLUENCE OF THEOPHYLLINE ON BOTH BRONCHOCONSTRICTION AND PLASMA EXTRAVASATION INDUCED BY ACETALDEHYDE IN GUINEA-PIGS, Arzneimittel-Forschung, 44-1(3), 1994, pp. 323-326
Acetaldehyde administered intravenously at various doses (20, 40 and 8
0 mg/kg) elicits a dose-dependent increase in intratracheal pressure (
ITP) and a proportional rise in histamine blood concentration in anaes
thetized guinea-pigs. Similar effects were observed in ovalbumin-sensi
tized guinea-pigs upon aerosol of acetaldehyde (20 mg/ml) which has be
en administered at the flow rate of 0.1 ml/min for 2 min. Theophylline
(CAS 58-55-9) antagonized both the increase of ITP values and the ris
e of histamine in the blood caused by acetaldehyde given intravenously
(ED50 = 5.8 mg/kg i. v.) or by aerosol (ED50 = 4.9 mg/kg i. v.). Furt
hermore, in animals where combined treatment with pyrilamine (2 mg/kg
i. v.) and captopril (2 mg/kg iv.) resulted in a remarkable potentiati
on of the bronchoconstrictor response to acetaldehyde (20 mg/kg i. v.)
, the administration of theophylline (5 mg/kg i. v. ) or of the substa
nce P (SP) receptor antagonist, [D-Pro4, D-Trp7.9] SP 4-11 (10 mg/kg i
v.) reduced the augmented action of acetaldehyde on respiratory airway
s induced by captopril by more than 50 %. Moreover, the bronchoconstri
ction induced by acetaldehyde (40 mg/kg i. v.) was also associated wit
h a significant increase of extravasation of Evans blue in tracheal ti
ssue. Both these effects of acetaldehyde were inhibited by theophyllin
e (10 mg/kg iv.), whereas a NK1-TK (neurokinin 1-tachykinin) receptor
antagonist (412 mug/kg i. v. ) reduced (81 %; p < 0.001) only the vasc
ular permeability changes caused by acetaldehyde. In conclusion, the p
rotecting activity observed with theophylline against acetaldehyde act
ions in guinea-pigs, takes place at doses inferior to those necessary
to antagonize acetylcholine-induced bronchoconstriction and appears to
involve the inhibition of histamine secretion and to control the acti
vation of sensory nerve endings and tachykinin release.